Site Logo
  1. Home
  2. Past Issues
  3. Summary Vol.78 Issue 6 / 2015
  4. Article
Original Articles
Views

Arq. Bras. Oftalmol. 2015; 78 (6): 10.5935/0004-2749.20150090

Total: 1070

Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity

Muhammet Kazim Erol1; Deniz Turgut Coban1; Esin Sogutlu Sari2; Ahmet Burak Bilgin3; Berna Dogan1; Ozdemir Ozdemir4; Zuhal Ozen Tunay4

DOI: 10.5935/0004-2749.20150090

1 Antalya Training and Research Hospital, Department of Ophthalmology, Antalya, Turkey.

2 Balikesir University, Medical School, Department of Ophthalmology, Balikesir, Turkey.

3 Akdeniz University, Medical School, Department of Ophthalmology, Antalya, Turkey.

4 Zekai Tahir Burak Hospital, Department of Ophthalmology, Ankara, Turkey.


Read in Portuguese XML Print PDF English
Open Access
Share

How to cite this article:

Kazim Erol M, Turgut Coban D, Sogutlu Sari E, Burak Bilgin A, Berna Dogan , Ozdemir Ozdemir , et al. Comparação de ranibizumab e bevacizumab intravítreos no tratamento da retinopatia da prematuridade. Arq. Bras. Oftalmol. 2015;78(6):. 10.5935/0004-2749.20150090
Export citation